ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

National Survey about Management of Venous Thromboembolism (VTE) Prevention in COVID-19 Patients in Uruguay

A. Pizzarossa1, M.N. Spangenberg1, F. Munka1, B. Borges1, M. Sosa1, F. Passarella1, M. Aguirre1, E. Falero1, C. Guillermo1

1Unidad de Hemostasis y Trombosis. Hospital de Clínicas. Facultad de Medicina, UdelaR, Montevideo, Uruguay

Abstract Number: PB0274

Meeting: ISTH 2021 Congress

Theme: COVID and Coagulation » COVID and Coagulation, Clinical

Background: Coagulopathy is one of the serious manifestations of COVID-19, however this infection is also related to an increased incidence of VTE. VTE prevention in these patients was not standardized, especially at the beginning of the pandemic.

Aims: To evaluate the VTE prevention strategies in patients with COVID-19 in Uruguay.

Methods: Descriptive observational study, based on an online survey, whose target population includes physicians from Uruguay who assisted COVID-19 patients. It was available online from 4/9 to 5/10/2020. However, given the increase in cases in Uruguay, the survey was relaunched in March 2021.  

Results: 42 physicians completed the survey. 29 assisted patients with moderate and 17 assisted patients with severe COVID-19 (4 assisted both groups).
Moderate COVID (required hospitalization)
23 used pharmacological and 2 used mechanical thromboprophylaxis. 12 used a LMWH dose of 40 mg/day, 7 used 1 mg/kg/day, 4 used 60 mg/day. 13 had doubts about whether to indicate thromboprophylaxis.10 requested D-dimers and in 9 cases they were augmented.
Severe COVID (required admission to ICU)
All used pharmacological thromboprophylaxis. 5 used a LMWH dose of 1 mg/kg every 12 hours, 4 used 40 mg/day, 4 used 1 mg/kg/day, 2 used 60 mg/day and 1 used 1.5 mg/kg/day.
16 requested D dimers, in all cases they were increased.
Regarding the preliminary results of the second phase. 17 doctors completed the survey, all of them cared for patients with moderate COVID. 14 used pharmacological thromboprophylaxis, 12 with doses of LMWH of 40 mg/day and 2 with doses of 1 mg/kg/day. 5 had doubts whether to indicate thromboprophylaxis. 11 cared for patients with severe COVID, 10 used pharmacological thromboprophylaxis (5 used LMWH 1 mg/kg every 12 hours, 2 used 1 mg/kg/day and 3 used 40 mg/day).

Conclusions: A heterogeneous approach to VTE prevention has been observed among physicians who cared for COVID-19 patients.

To cite this abstract in AMA style:

Pizzarossa A, Spangenberg MN, Munka F, Borges B, Sosa M, Passarella F, Aguirre M, Falero E, Guillermo C. National Survey about Management of Venous Thromboembolism (VTE) Prevention in COVID-19 Patients in Uruguay [abstract]. Res Pract Thromb Haemost. 2021; 5 (Suppl 2). https://abstracts.isth.org/abstract/national-survey-about-management-of-venous-thromboembolism-vte-prevention-in-covid-19-patients-in-uruguay/. Accessed November 29, 2023.

« Back to ISTH 2021 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/national-survey-about-management-of-venous-thromboembolism-vte-prevention-in-covid-19-patients-in-uruguay/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley